glp-1 obesity drug updates today New oral delivers up to 12% weight loss in 36 weeks GLP-1 Receptor Agonists Obesity Drugs

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes mellitus (LEAD-4 Met + TZD)

Effects of the glucagon-like peptide-1 (GLP-1) analogues semaglutide and liraglutide on renal outcomes a pooled analysis of the SUSTAIN 6 and LEADER trials

Neumiller, Mindy M

Ling S, Zaccardi F, Issa E, Davies MJ, Khunti K, Brown K

Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease

Indeed, GLP-1 RAs may support the preservation of muscle mass and function through improvements in glycemic control, weight reduction, and indirect modulation of inflammatory responses [81]